Kangji Medical Holdings Limited

SEHK:9997 株式レポート

時価総額:HK$6.8b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Kangji Medical Holdings マネジメント

マネジメント 基準チェック /44

Kangji Medical Holdings'の CEO はMing Zhongで、 Aug2004年に任命され、 の在任期間は 19.83年です。 の年間総報酬はCN¥ 1.23Mで、 96.2%給与と3.8%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の33.7%を直接所有しており、その価値はHK$ 2.41B 。経営陣と取締役会の平均在任期間はそれぞれ3.4年と4.3年です。

主要情報

Ming Zhong

最高経営責任者

CN¥1.2m

報酬総額

CEO給与比率96.2%
CEO在任期間19.9yrs
CEOの所有権33.7%
経営陣の平均在職期間3.5yrs
取締役会の平均在任期間4.3yrs

経営陣の近況

Recent updates

Investors Could Be Concerned With Kangji Medical Holdings' (HKG:9997) Returns On Capital

Apr 12
Investors Could Be Concerned With Kangji Medical Holdings' (HKG:9997) Returns On Capital

Kangji Medical Holdings Limited (HKG:9997) Shares Could Be 32% Above Their Intrinsic Value Estimate

Mar 08
Kangji Medical Holdings Limited (HKG:9997) Shares Could Be 32% Above Their Intrinsic Value Estimate

Kangji Medical Holdings Limited's (HKG:9997) Share Price Not Quite Adding Up

Dec 21
Kangji Medical Holdings Limited's (HKG:9997) Share Price Not Quite Adding Up

Kangji Medical Holdings' (HKG:9997) Returns On Capital Not Reflecting Well On The Business

Oct 23
Kangji Medical Holdings' (HKG:9997) Returns On Capital Not Reflecting Well On The Business

Should You Be Adding Kangji Medical Holdings (HKG:9997) To Your Watchlist Today?

Aug 17
Should You Be Adding Kangji Medical Holdings (HKG:9997) To Your Watchlist Today?

A Look At The Intrinsic Value Of Kangji Medical Holdings Limited (HKG:9997)

Jul 28
A Look At The Intrinsic Value Of Kangji Medical Holdings Limited (HKG:9997)

Kangji Medical Holdings (HKG:9997) Will Be Hoping To Turn Its Returns On Capital Around

May 16
Kangji Medical Holdings (HKG:9997) Will Be Hoping To Turn Its Returns On Capital Around

Is Now The Time To Put Kangji Medical Holdings (HKG:9997) On Your Watchlist?

May 01
Is Now The Time To Put Kangji Medical Holdings (HKG:9997) On Your Watchlist?

Some Shareholders Feeling Restless Over Kangji Medical Holdings Limited's (HKG:9997) P/E Ratio

Apr 13
Some Shareholders Feeling Restless Over Kangji Medical Holdings Limited's (HKG:9997) P/E Ratio

A Look At The Fair Value Of Kangji Medical Holdings Limited (HKG:9997)

Mar 28
A Look At The Fair Value Of Kangji Medical Holdings Limited (HKG:9997)

Here's Why Kangji Medical Holdings (HKG:9997) Has Caught The Eye Of Investors

Jan 03
Here's Why Kangji Medical Holdings (HKG:9997) Has Caught The Eye Of Investors

Are Kangji Medical Holdings Limited (HKG:9997) Investors Paying Above The Intrinsic Value?

Sep 21
Are Kangji Medical Holdings Limited (HKG:9997) Investors Paying Above The Intrinsic Value?

Kangji Medical Holdings (HKG:9997) Is Reinvesting At Lower Rates Of Return

Jun 12
Kangji Medical Holdings (HKG:9997) Is Reinvesting At Lower Rates Of Return

Kangji Medical Holdings' (HKG:9997) Shareholders Will Receive A Bigger Dividend Than Last Year

May 16
Kangji Medical Holdings' (HKG:9997) Shareholders Will Receive A Bigger Dividend Than Last Year

Kangji Medical Holdings (HKG:9997) Will Pay A Larger Dividend Than Last Year At HK$0.17

May 02
Kangji Medical Holdings (HKG:9997) Will Pay A Larger Dividend Than Last Year At HK$0.17

Returns On Capital At Kangji Medical Holdings (HKG:9997) Paint A Concerning Picture

Dec 20
Returns On Capital At Kangji Medical Holdings (HKG:9997) Paint A Concerning Picture

Analysts Just Slashed Their Kangji Medical Holdings Limited (HKG:9997) EPS Numbers

Mar 31
Analysts Just Slashed Their Kangji Medical Holdings Limited (HKG:9997) EPS Numbers

Here's Why We Think Kangji Medical Holdings' (HKG:9997) Statutory Earnings Might Be Conservative

Feb 03
Here's Why We Think Kangji Medical Holdings' (HKG:9997) Statutory Earnings Might Be Conservative

Does Kangji Medical Holdings Limited (HKG:9997) Create Value For Shareholders?

Dec 30
Does Kangji Medical Holdings Limited (HKG:9997) Create Value For Shareholders?

An Intrinsic Calculation For Kangji Medical Holdings Limited (HKG:9997) Suggests It's 42% Undervalued

Nov 25
An Intrinsic Calculation For Kangji Medical Holdings Limited (HKG:9997) Suggests It's 42% Undervalued

CEO報酬分析

Kangji Medical Holdings の収益と比較して、Ming Zhong の報酬はどのように変化したか?
日付総報酬給与会社業績
Dec 31 2023CN¥1mCN¥1m

CN¥504m

Sep 30 2023n/an/a

CN¥540m

Jun 30 2023n/an/a

CN¥576m

Mar 31 2023n/an/a

CN¥528m

Dec 31 2022CN¥1mCN¥1m

CN¥479m

Sep 30 2022n/an/a

CN¥447m

Jun 30 2022n/an/a

CN¥415m

Mar 31 2022n/an/a

CN¥436m

Dec 31 2021CN¥1mCN¥990k

CN¥457m

報酬と市場: Mingの 総報酬 ($USD 169.80K ) は、 Hong Kong市場 ($USD 464.86K ) の同様の規模の企業の平均を下回っています。

報酬と収益: Mingの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Ming Zhong (48 yo)

19.9yrs

在職期間

CN¥1,232,000

報酬

Mr. Ming Zhong serves as Executive Director of Kangji Medical Holdings Limited since March 7, 2020 and Chief Executive Officer since August 24, 2004 and is its Executive Chairman since May 2024. He is main...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Ming Zhong
Executive Chairman of the Board & CEO19.9yrsCN¥1.23m33.74%
CN¥ 2.3b
Yinguang Shentu
Vice GM & Executive Director7.7yrsCN¥1.03m19.12%
CN¥ 1.3b
Frances Fang Chovanec
Executive Directorless than a yearCN¥4.80mデータなし
Zixin Yin
Vice GM & Executive Director4.3yrsCN¥1.94mデータなし
Yanyu Hu
Chief Financial Officerless than a yearデータなしデータなし
Jianyong Ju
Head of Domestic Sales & Marketing3.5yrsデータなしデータなし
Siu Keung Wan
Company Secretary2.2yrsデータなしデータなし

3.5yrs

平均在職期間

45yo

平均年齢

経験豊富な経営陣: 9997の経営陣は 経験豊富 であると考えられます ( 3.4年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Ming Zhong
Executive Chairman of the Board & CEO4.4yrsCN¥1.23m33.74%
CN¥ 2.3b
Yinguang Shentu
Vice GM & Executive Director4.3yrsCN¥1.03m19.12%
CN¥ 1.3b
Frances Fang Chovanec
Executive Directorless than a yearCN¥4.80mデータなし
Zixin Yin
Vice GM & Executive Director2.3yrsCN¥1.94mデータなし
Jian Guo
Independent Non-Executive Director4.3yrsCN¥102.00kデータなし
Lydia Cai
Non-Executive Director4.3yrsデータなしデータなし
Weibo Chen
Independent Non-Executive Director4.3yrsCN¥102.00kデータなし
Feng Jiang
Independent Non-Executive Director4.3yrsCN¥102.00kデータなし

4.3yrs

平均在職期間

48yo

平均年齢

経験豊富なボード: 9997の 取締役会経験豊富 であると考えられます ( 4.3年の平均在任期間)。